|
|
|
|
| LEADER |
01714nam a2200337 u 4500 |
| 001 |
EB001839568 |
| 003 |
EBX01000000000000001003557 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Home isolation to prevent tuberculosis transmission
|h Elektronische Ressource
|b a review of the clinical evidence and guidelines
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
| 246 |
3 |
1 |
|a Home isolation for tuberculosis
|
| 260 |
|
|
|a [Ottawa, Ontario]
|b Canadian Agency for Drugs and Technologies in Health
|c 2014, 05 May 2014
|
| 300 |
|
|
|a 1 PDF file (17 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Patient Isolation
|
| 653 |
|
|
|a Home Care Services
|
| 653 |
|
|
|a Tuberculosis, Pulmonary / transmission
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Guidelines as Topic
|
| 653 |
|
|
|a Tuberculosis, Pulmonary / prevention & control
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report : summary with critical appraisal
|
| 500 |
|
|
|a Title from PDF caption title
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK264094
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to assess the literature reporting on home (versus hospital) isolation of individuals with active tuberculosis (TB) including the guidance contained in relevant evidence-based clinical practice guidelines (CPGs)
|